Novartis Investigative Site

Burlington, Massachusetts 01805

0 studies enrolling now · 9 studies all time

What they study most

Acute Leukaemia, Atherosclerosis, Cancer, Cardiovascular Disease, Chronic Kidney Disease (CKD), Chronic Obstructive Pulmonary Disease (COPD), End Stage Renal Disease (ESRD), Hemodialysis, Liver Transplantation, Lymphoma, Non-Hodgkin, Moderate to Severe Allergic Asthma, Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• A Safety and Efficacy Study of Eltrombopag in Subjects With AML — Completed
• Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants — Completed
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM) — Completed
• Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease — Completed
• Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma — Completed